X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GSK PHARMA TTK HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x 22.9 67.5 34.0% View Chart
P/BV x 7.7 13.6 56.8% View Chart
Dividend Yield % 0.4 2.1 17.8%  

Financials

 TTK HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
GSK PHARMA
Mar-18
TTK HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6632,760 24.0%   
Low Rs3992,040 19.6%   
Sales per share (Unadj.) Rs535.6339.0 158.0%  
Earnings per share (Unadj.) Rs15.941.4 38.5%  
Cash flow per share (Unadj.) Rs20.045.9 43.6%  
Dividends per share (Unadj.) Rs4.0035.00 11.4%  
Dividend yield (eoy) %0.81.5 51.6%  
Book value per share (Unadj.) Rs137.6242.9 56.7%  
Shares outstanding (eoy) m7.7784.70 9.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.07.1 14.0%   
Avg P/E ratio x33.357.9 57.5%  
P/CF ratio (eoy) x26.552.3 50.7%  
Price / Book Value ratio x3.99.9 39.1%  
Dividend payout %25.184.5 29.7%   
Avg Mkt Cap Rs m4,127203,280 2.0%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6075,234 11.6%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16228,715 14.5%  
Other income Rs m61545 11.2%   
Total revenues Rs m4,22329,260 14.4%   
Gross profit Rs m1975,059 3.9%  
Depreciation Rs m32380 8.3%   
Interest Rs m302 1,495.0%   
Profit before tax Rs m1975,222 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m731,892 3.8%   
Profit after tax Rs m1243,508 3.5%  
Gross profit margin %4.717.6 26.9%  
Effective tax rate %37.036.2 102.2%   
Net profit margin %3.012.2 24.4%  
BALANCE SHEET DATA
Current assets Rs m1,62921,815 7.5%   
Current liabilities Rs m1,05815,999 6.6%   
Net working cap to sales %13.720.3 67.7%  
Current ratio x1.51.4 112.9%  
Inventory Days Days3064 46.8%  
Debtors Days Days3419 179.8%  
Net fixed assets Rs m55612,475 4.5%   
Share capital Rs m78847 9.2%   
"Free" reserves Rs m87819,726 4.5%   
Net worth Rs m1,06920,573 5.2%   
Long term debt Rs m1596 2,645.0%   
Total assets Rs m2,39939,475 6.1%  
Interest coverage x7.62,612.0 0.3%   
Debt to equity ratio x0.10 50,889.7%  
Sales to assets ratio x1.70.7 238.5%   
Return on assets %6.48.9 72.1%  
Return on equity %11.617.1 68.0%  
Return on capital %18.526.2 70.3%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m33564 5.8%   
Fx outflow Rs m637,429 0.9%   
Net fx Rs m-30-6,865 0.4%   
CASH FLOW
From Operations Rs m1274,728 2.7%  
From Investments Rs m-146-1,042 14.0%  
From Financial Activity Rs m22-3,066 -0.7%  
Net Cashflow Rs m3620 0.4%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.7 10.2 36.3%  
FIIs % 5.2 23.8 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 102,036 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  FULFORD INDIA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 235.3% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, GSK PHARMA has posted a net profit of Rs 886 m (up 235.3% YoY). Sales on the other hand came in at Rs 7 bn (up 21.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - AUROBINDO PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS